Mostrar el registro sencillo del ítem

dc.contributor.authorPérez-Moreno, Pablo
dc.contributor.authorRiquelme, Ismael
dc.contributor.authorGarcía, Patricia
dc.contributor.authorBrebi, Priscilla
dc.contributor.authorRoa, Juan Carlos
dc.date.accessioned2024-04-10T06:45:05Z
dc.date.available2024-04-10T06:45:05Z
dc.date.issued2022
dc.identifier10.3390/jpm12020234
dc.identifier.issn20754426
dc.identifier.urihttps://hdl.handle.net/20.500.12728/11078
dc.description.abstractGallbladder cancer (GBC) is an aggressive neoplasm that in an early stage is generally asymptomatic and, in most cases, is diagnosed in advanced stages with a very low life expectancy because there is no curative treatment. Therefore, understanding the early carcinogenic mechanisms of this pathology is crucial to proposing preventive strategies for this cancer. The main risk factor is the presence of gallstones, which are associated with some environmental factors such as a sedentary lifestyle and a high-fat diet. Other risk factors such as autoimmune disorders and bacterial, parasitic and fungal infections have also been described. All these factors can generate a long-term inflammatory state characterized by the persistent activation of the immune system, the frequent release of pro-inflammatory cytokines, and the constant production of reactive oxygen species that result in a chronic damage/repair cycle, subsequently inducing the loss of the normal architecture of the gallbladder mucosa that leads to the development of GBC. This review addresses how the different risk factors could promote a chronic inflammatory state essential to the development of gallbladder carcinogenesis, which will make it possible to define some strategies such as anti-inflammatory drugs or public health proposals in the prevention of GBC. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.es_ES
dc.description.sponsorshipDIUA, (226-2021); DIUFRO, (DI20-0128); Universidad Autónoma de Chile; Horizon 2020 Framework Programme, H2020, (825510); European Research Council, ERC; Fondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT, (1210440, 1221345, 3210237); Universidad de La Frontera, UFRO; Fondo de Fomento al Desarrollo Científico y Tecnológico, FONDEF, (ID21I10027); Instituto Milenio en Inmunología e Inmunoterapia, MIII, (ICN2021_045)es_ES
dc.language.isoenes_ES
dc.publisherMDPIes_ES
dc.subjectCarcinogenesises_ES
dc.subjectGallbladder canceres_ES
dc.subjectRisk factorses_ES
dc.titleEnvironmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Canceres_ES
dc.typeArticlees_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem